![Sodium–Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies | SpringerLink Sodium–Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13300-021-01004-2/MediaObjects/13300_2021_1004_Fig8_HTML.png)
Sodium–Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies | SpringerLink
![JCDD | Free Full-Text | Performance of Copeptin for Early Diagnosis of Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of 14,139 Patients JCDD | Free Full-Text | Performance of Copeptin for Early Diagnosis of Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of 14,139 Patients](https://pub.mdpi-res.com/jcdd/jcdd-09-00006/article_deploy/html/images/jcdd-09-00006-g001-550.jpg?1640675772)
JCDD | Free Full-Text | Performance of Copeptin for Early Diagnosis of Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of 14,139 Patients
![JCM | Free Full-Text | The Link between Stroke Risk and Orodental Status—A Comprehensive Review JCM | Free Full-Text | The Link between Stroke Risk and Orodental Status—A Comprehensive Review](https://www.mdpi.com/jcm/jcm-11-05854/article_deploy/html/images/jcm-11-05854-g001.png)
JCM | Free Full-Text | The Link between Stroke Risk and Orodental Status—A Comprehensive Review
![Hospital Insulin Protocol Aims For Glucose Control In Glucocorticoid-Induced Hyperglycemia - Endocrine Practice Hospital Insulin Protocol Aims For Glucose Control In Glucocorticoid-Induced Hyperglycemia - Endocrine Practice](https://www.endocrinepractice.org/cms/attachment/baf59df4-db67-49aa-b4a9-495fd7713198/gr1.jpg)
Hospital Insulin Protocol Aims For Glucose Control In Glucocorticoid-Induced Hyperglycemia - Endocrine Practice
![IJMS | Free Full-Text | Hypertension in Patients with Insulin Resistance: Etiopathogenesis and Management in Children IJMS | Free Full-Text | Hypertension in Patients with Insulin Resistance: Etiopathogenesis and Management in Children](https://www.mdpi.com/ijms/ijms-23-05814/article_deploy/html/images/ijms-23-05814-g001.png)
IJMS | Free Full-Text | Hypertension in Patients with Insulin Resistance: Etiopathogenesis and Management in Children
![Sex-specific impact of diabetes mellitus on left ventricular systolic function and prognosis in heart failure | Scientific Reports Sex-specific impact of diabetes mellitus on left ventricular systolic function and prognosis in heart failure | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-91170-x/MediaObjects/41598_2021_91170_Fig1_HTML.png)
Sex-specific impact of diabetes mellitus on left ventricular systolic function and prognosis in heart failure | Scientific Reports
![Prognosis in patients with atrial fibrillation and type 1 diabetes, type 2 diabetes and severe hypoglycaemia: a nationwide report - Media Centre | EASD Prognosis in patients with atrial fibrillation and type 1 diabetes, type 2 diabetes and severe hypoglycaemia: a nationwide report - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/1059_719514_1/Slide1.jpg)
Prognosis in patients with atrial fibrillation and type 1 diabetes, type 2 diabetes and severe hypoglycaemia: a nationwide report - Media Centre | EASD
Lifetime risk of developing diabetes in Chinese people with normoglycemia or prediabetes: A modeling study | PLOS Medicine
![Kerstin ELVIN | Senior consultant | MD PhD | Karolinska University Hospital, Stockholm | Karolinska | Department of Clinical Immunology and Transfusion Medicine | Research profile Kerstin ELVIN | Senior consultant | MD PhD | Karolinska University Hospital, Stockholm | Karolinska | Department of Clinical Immunology and Transfusion Medicine | Research profile](https://i1.rgstatic.net/ii/profile.image/272738812166168-1442037408862_Q512/Kerstin-Elvin.jpg)
Kerstin ELVIN | Senior consultant | MD PhD | Karolinska University Hospital, Stockholm | Karolinska | Department of Clinical Immunology and Transfusion Medicine | Research profile
![Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial - The Lancet Diabetes Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial - The Lancet Diabetes](https://www.thelancet.com/cms/attachment/70b98ada-bbc5-422e-b780-fada19a63a33/gr1_lrg.jpg)
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial - The Lancet Diabetes
![Atherosclerosis Impairs Naive CD4 T-Cell Responses via Disruption of Glycolysis | Arteriosclerosis, Thrombosis, and Vascular Biology Atherosclerosis Impairs Naive CD4 T-Cell Responses via Disruption of Glycolysis | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/cf19702f-f58f-457d-a333-8f6634033c2e/atvbaha.120.314189.fig07.jpg)
Atherosclerosis Impairs Naive CD4 T-Cell Responses via Disruption of Glycolysis | Arteriosclerosis, Thrombosis, and Vascular Biology
![IJMS | Free Full-Text | Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients? IJMS | Free Full-Text | Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?](https://pub.mdpi-res.com/ijms/ijms-23-14598/article_deploy/html/images/ijms-23-14598-g001.png?1669349494)
IJMS | Free Full-Text | Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?
![JCM | Free Full-Text | Low FT3/FT4 Ratio Is Linked to Poor Prognosis of Acute Myocardial Infarction in Euthyroid Patients with Type 2 Diabetes Mellitus JCM | Free Full-Text | Low FT3/FT4 Ratio Is Linked to Poor Prognosis of Acute Myocardial Infarction in Euthyroid Patients with Type 2 Diabetes Mellitus](https://www.mdpi.com/jcm/jcm-11-06530/article_deploy/html/images/jcm-11-06530-g001.png)
JCM | Free Full-Text | Low FT3/FT4 Ratio Is Linked to Poor Prognosis of Acute Myocardial Infarction in Euthyroid Patients with Type 2 Diabetes Mellitus
![Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects - Journal of Molecular and Cellular Cardiology Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects - Journal of Molecular and Cellular Cardiology](https://www.jmcc-online.com/cms/attachment/40342408-2f7e-4c60-acc2-1240f8d20b68/ga1_lrg.jpg)
Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects - Journal of Molecular and Cellular Cardiology
![Switching to Versus Addition of Incretin‐Based Drugs Among Patients With Type 2 Diabetes Taking Sodium‐Glucose Cotransporter‐2 Inhibitors | Journal of the American Heart Association Switching to Versus Addition of Incretin‐Based Drugs Among Patients With Type 2 Diabetes Taking Sodium‐Glucose Cotransporter‐2 Inhibitors | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/de36fdc5-e9e5-49c1-aac3-57dc8363a91c/jah37324-fig-0001.png)
Switching to Versus Addition of Incretin‐Based Drugs Among Patients With Type 2 Diabetes Taking Sodium‐Glucose Cotransporter‐2 Inhibitors | Journal of the American Heart Association
![Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with a Preserved Ejection Fraction: A Meta-Analysis of Randomized Controlled Trials Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with a Preserved Ejection Fraction: A Meta-Analysis of Randomized Controlled Trials](https://article.imrpress.com/journal/RCM/23/11/10.31083/j.rcm2311374/2153-8174-23-11-374/fig1.jpg)